Department of Medicine, Center for Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
Mucosal Immunol. 2011 Jan;4(1):4-7. doi: 10.1038/mi.2010.79. Epub 2010 Dec 8.
Although it is generally accepted that the distal gut microbiota are relatively stable in healthy adult individuals, a collapse of the microbial community structure resulting from antibiotic therapy or pathogen presence can lead to gut dysfunction. However, recent findings demonstrate that it is possible to engraft new microbiota from a donor source, resulting in the restoration of gut functionality and improvement in health. This builds upon decades of case reports and series in which fecal transfers were used to successfully treat refractory and recurrent Clostridium difficile infection. As fecal transplantation becomes part of mainstream medicine, it will likely provide a unique opportunity to study the interactions of humans with their attendant microbiota and allow greater insights into their synergistic functionality.
尽管人们普遍认为健康成年人的远端肠道微生物群落相对稳定,但抗生素治疗或病原体存在导致的微生物群落结构崩溃可导致肠道功能障碍。然而,最近的研究结果表明,从供体来源植入新的微生物群落是可能的,从而恢复肠道功能并改善健康。这是基于数十年来的病例报告和系列研究,其中粪便移植被用于成功治疗难治性和复发性艰难梭菌感染。随着粪便移植成为主流医学的一部分,它可能为研究人类与其伴随的微生物群落的相互作用提供独特的机会,并更深入地了解它们的协同功能。